MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
IVERIC bio, Inc. (Nasdaq: ISEE), formerly Ophthotech
Organization & Developments: IVERIC bio
Parents
IVERIC bio, Inc. (Nasdaq: ISEE), formerly Ophthotech
Children
2019: IVERIC bio: Promising Data In GA, Valuation Still Cheap With Multiple Catalysts In 2020_seekingalpha.com
2020: Iveric bio: Much More Upside Ahead_seekingalpha.com
2022: IVERIC bio (ISEE) Investor Presentation - Slideshow_ seekingalpha.com
2022: Iveric bio: Building Momentum Around Zimura, Rate Buy_seekingalpha.com
2022: Iveric bio: Further Upside Possible Based On Expanded Opportunities With Zimura_seekingalpha.com
2023: Astellas Enters into Definitive Agreement to Acquire Iveric Bio
IVERIC bio, Inc., a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases.
Ophthotech (NASDAQ: OPHT)
Jumps
*Key People: IVERIC bio
Finance & Acquisitions: IVERIC bio